BTG International

London, United Kingdom Founded: 1948 • Age: 78 yrs Listed Acquired By Boston Scientific
Therapeutics are developed for oncology, pulmonology, hematology, and anti-venom treatments.

About BTG International

BTG International is a Healthcare company based in London (United Kingdom) founded in 1948, and was acquired by Boston Scientific in November 2018. Therapeutics are developed for oncology, pulmonology, hematology, and anti-venom treatments. The company has 1 employees. BTG International has completed 7 acquisitions, including Biocompatibles, EKOS Corporation and Galil Medical. BTG International offers products and services including Defibrillators, Pacemakers, and Spinal Cord Stimulators. Its focus areas include Life Sciences, Cardiac and Vascular Disorders, Medical Devices and Therapeutic Devices. Its legal entity is BTG INTERNATIONAL LIMITED.

Company details

BTG International was founded in 1948 in London, United Kingdom, within the pharmaceuticals sector. Therapeutic agents are developed for disorders including neurological conditions, varicose veins, liver cancer, blood clots, and emphysema. Operations span three segments: Interventional Medicine, covering oncology products like TheraSphere, vascular treatments such as Varithena, and pulmonology options like PneumRx Coil. Antidote products, including CroFab for snake envenomations and DigiFab for digoxin toxicity, are also provided.

  • Headquarters London, United Kingdom
  • Employees 1
  • Stage Acquired
  • Sectors
    Healthcare
  • Website btgplc.com
  • Social LinkedIn
  • Acquired by Boston Scientific (Nov 2018)
  • Legal Name Btg International Limited
  • Date of Incorporation 14 Nov, 1991
  • Jurisdiction FARNHAM, SURREY
Key Metrics
  • Annual Revenue
    $173.79 M (USD)
    7
    as on Dec 31, 2020
  • Net Profit
    $58.14 M (USD)
    11
    as on Dec 31, 2020
  • Latest Funding Round
    $5.5M (USD), Post-IPO

    Jan 2011

  • Investors
  • Employee Count
    1
  • Investments & Acquisitions
  • Acquired by

Products & Services of BTG International

BTG International offers a comprehensive portfolio of products and services, including Defibrillators, Pacemakers, and Spinal Cord Stimulators.

Defibrillators
Heart Devices

Devices that treat cardiac arrhythmias and save lives.

Pacemakers
Heart Devices

Implants that regulate heart rhythm for patients.

Spinal Cord Stimulators
Pain Management

Systems that alleviate chronic pain through stimulation.

Funding Insights of BTG International

  • Total Rounds 6
  • Last Round Post-IPO β€” $5.5M
  • First Round $336,875

    (May 2008)

  • Investors Count 1

All 6 funding rounds of BTG International with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Jan 2011$5.5MPost-IPO––
–
Jan 2011$385,000Grant––
Jan 2011$385,000Grant––
Jun 2010$2.79MGrant––
Jun 2008$336,875Grant––
May 2008$336,875Grant––
Valuation history

2 investors in total: 2 institutional.

Investors in BTG International

BTG International has secured backing from 2 investors, including institutional investors. Prominent investors backing the company include Boston Scientific and HHS.

All
Institutional
InvestorDescriptionFounded YearDomainLocation
Public health and human services are overseen by HHS.
1953hhs.gov
Wide range of medical devices
1979bostonscientific.comMarlborough, United States
Premium access

Investor details for BTG International

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

People of BTG International

1150 people are tracked at BTG International (315 in leadership, 9 in board & advisors, 826 in team); the tracked headcount is 1.

NameRoleGroup
Augusto Chaves
IT PMO & Finance HeadLeadership
Genevieve Morrison
IT Director, Acquisition & IntegrationsLeadership
David Sapienza
VP Global Operation Distribution And LogisticsLeadership
Nikunj Murgai
Director, ITLeadership
Jodi Eddy
Senior Vice President, Enterprise Services and Digital OfficerLeadership
Siri Thompson
Vice President, Program Management LAACLeadership
Lance Bates
SVP & President, Interventional Cardiology TherapiesLeadership
Alex Pflugfelder
Director - Upstream EP Marketing, EP Commercial Development TeamLeadership
Sofía Leiva
HR Specialist - People Services Partner LatamLeadership
Zoe Heuver
Supply Chain PartnerLeadership
Charles K.
Director, QualityLeadership
Ahmed Abdelaal
Chief Medical OfficerLeadership
Lillian Kerrigan
Director Global Quality Design Controls And AcquisitionsLeadership
Viktoriya Skuz
People Partner ILeadership
Kelly Schwenn
Director Of Program Management, Arden Hills And North America ManufacturingLeadership
Charudatta Aradhye
Associate Director, R&DLeadership
Sandra Nagale
Director, Digital Health Products, Platforms & AILeadership
Gary Leblanc
Director Of QualityLeadership
Janet Bukovcan
Director, Regulatory AffairsLeadership
Philip Sinclair
Vice President, Global Medical Affairs And Clinical Development, Interventional OncologyLeadership

1130 more people are available in the full profile.

Premium access

Complete people profiles for BTG International

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Investments & Acquisitions by BTG International

BTG International has strategically engaged in corporate development activities, having acquired 7 companies. Notable acquisitions include Biocompatibles, EKOS Corporation and Galil Medical.

Acquisitions
Company NameDescriptionDomainLocationFoundedAcquiredAmount
Obstetric device developed to prevent childbirth infections.
novatemedical.comNew Orleans, United States2010Sep 2018$20M
Inferior vena cava filters are developed for pulmonary embolism treatment.
novate.bizGalway, Ireland2006Sep 2018$150M
Catheters for interventional cardiology in arterial disease are developed.
roxwoodmedical.comRedwood, United States2011Oct 2017$80M
A platform offering an online slot game for entertainment.
galilmedical.comArden Hills, United States1996May 2016$84.5M
Minimally invasive emphysema treatments using Nitinol lung coils are developed.
pneumrx.comMountain View, United States2004Dec 2014$230M
Ultrasound thrombolytic devices for pulmonary embolism treatment are developed.
ekoscorp.comBothell, United States1995May 2013$180M
UK-based biotherapeutics company developing products for the treatment of liver and HCC cancer.
biocompatibles.comFarnham, United Kingdom1998Nov 2010β€’β€’β€’β€’
Premium access

Complete acquisition details for BTG International

Acquired stakes, deal sources and the complete acquisition history require an active premium plan.

  • Acquired stakes
  • Deal sources
  • Complete history
  • Exports

Verified entity values are shown only after access is granted.

Timeline of BTG International

12 dated milestones of BTG International across 70 years, from founding to its latest funding, stage changes and deals.

  1. Founded BTG International is founded.
  2. IPO Lists on the stock exchange (IPO).
  3. Funding First funding round of $337K.
  4. Acquisition Acquires Biocompatibles.
  5. Funding Latest funding round, Post-IPO, of $5.5M.
  6. Acquisition Acquires EKOS Corporation.
  7. Acquisition Acquires PneumRx.
  8. Acquisition Acquires Galil Medical.
  9. Acquisition Acquires Roxwood Medical.
  10. Acquisition Acquires Novate Medical.
  11. Acquisition Acquires Novate.
  12. Exit Acquired by Boston Scientific.

Web traffic of BTG International

Websites that share an audience with BTG International (btgplc.com).

Similar websites

Websites whose visitors overlap most with BTG International. Affinity shows how closely the audiences match.

WebsiteDomainAudience affinityMonthly visitsGlobal rankProfile
astrazeneca.com
100%
1.3M#48,983View details
amgen.com
79%
495.4K#116,434View details
inovio.com
77%
11.7K#1,670,423View details
ipsen.com
76%
112.9K#336,868View details
novartis.net
novartis.net
76%
–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’β€’.comβ€’β€’%β€’.β€’M#‒‒‒‒‒–
Premium access

All 13 similar websites and full traffic analytics for BTG International

The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.

  • 13 similar websites
  • Audience overlap
  • Engagement analytics
  • Traffic by brand

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Related news about Btg International

Premium access

Complete news archive for BTG International

Full article history, source details, and older brand coverage require an active premium plan.

  • Full article archive
  • Source and publication date
  • Older coverage
  • Brand-specific news history

Verified entity values are shown only after access is granted.

Frequently Asked Questions about BTG International

BTG International was founded in 1948 and raised its 1st funding round 60 years after it was founded.

BTG International is headquartered in London, United Kingdom. It is registered at London, England, United Kingdom.

BTG International has 1 employees.

Annual revenue of BTG International is $173.79M as on Dec 31, 2020.

BTG International was founded in 1948 in London, United Kingdom, within the pharmaceuticals sector. Therapeutic agents are developed for disorders including neurological conditions, varicose veins, liver cancer, blood clots, and emphysema. Operations span three segments: Interventional Medicine, covering oncology products like TheraSphere, vascular treatments such as Varithena, and pulmonology options like PneumRx Coil. Antidote products, including CroFab for snake envenomations and DigiFab for digoxin toxicity, are also provided.

BTG International offers Defibrillators, Pacemakers, and Spinal Cord Stimulators.

BTG International has made 7 acquisitions, including Biocompatibles, EKOS Corporation, and Galil Medical.

BTG International has 2 investors. Key investors include Boston Scientific, and HHS.

BTG International operates through Btg International Limited.

Yes. BTG International was acquired by Boston Scientific in November 2018.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available